Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance

Seminars in Oncology

Volumn 23, Issue 1, 1996, Pages 46-65

  Koc, O N ^a   Allay, J A ^a   Lee, K ^a   Davis, B M ^a   Reese, J S ^a   Gerson, S L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; ALDEHYDE DEHYDROGENASE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; DIHYDROFOLATE REDUCTASE; DOXORUBICIN; GLYCOPROTEIN P; METHOTREXATE; METHYLTRANSFERASE; PACLITAXEL; SUPEROXIDE DISMUTASE; VINBLASTINE;

BONE MARROW SUPPRESSION; CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DRUG MEGADOSE; DRUG RESISTANCE; EXCISION REPAIR; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW;

ALDEHYDE DEHYDROGENASE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG TOLERANCE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEMATOPOIETIC STEM CELLS; HUMANS; METHYLTRANSFERASES; NEOPLASMS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; P-GLYCOPROTEIN; SUPEROXIDE DISMUTASE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 0029869963     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)